Literature DB >> 85057

Dried-blood spot screening for cystic fibrosis in the newborn.

J R Crossley, R B Elliott, P A Smith.   

Abstract

Serum-immunoreactive-trypsin (I.R.T.) was measured in children with cystic fibrosis (C.F.) and a variety of controls. In the first few months of life all C.F. children had a raised serum-I.R.T. A dried blood-spot assay for I.R.T. was established and has potential as a screening test for C.F. in the newborn.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 85057     DOI： 10.1016/s0140-6736(79)90825-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  83 in total

Review 1.  Cystic fibrosis--an Indian perspective on recent advances in diagnosis and management.

Authors:  S K Kabra; M Kabra; M Ghosh; I C Verma
Journal:  Indian J Pediatr       Date:  1996 Mar-Apr       Impact factor: 1.967

2.  Protracted neonatal hypertrypsinogenaemia, normal sweat chloride, and cystic fibrosis.

Authors:  C Castellani; A Tamanini; G Mastella
Journal:  Arch Dis Child       Date:  2000-06       Impact factor: 3.791

3.  Implementation of the first worldwide quality assurance program for cystic fibrosis multiple mutation detection in population-based screening.

Authors:  Marie C Earley; Anita Laxova; Philip M Farrell; Rena Driscoll-Dunn; Suzanne Cordovado; Peter J Mogayzel; Michael W Konstan; W Harry Hannon
Journal:  Clin Chim Acta       Date:  2011-04-14       Impact factor: 3.786

Review 4.  Newborn screening for cystic fibrosis: the practical implications.

Authors:  Kevin W Southern
Journal:  J R Soc Med       Date:  2004       Impact factor: 5.344

5.  CFTR mutation analysis and haplotype associations in CF patients.

Authors:  S K Cordovado; M Hendrix; C N Greene; S Mochal; M C Earley; P M Farrell; M Kharrazi; W H Hannon; P W Mueller
Journal:  Mol Genet Metab       Date:  2011-10-26       Impact factor: 4.797

6.  A decision-tree approach to cost comparison of newborn screening strategies for cystic fibrosis.

Authors:  Janelle Wells; Marjorie Rosenberg; Gary Hoffman; Michael Anstead; Philip M Farrell
Journal:  Pediatrics       Date:  2012-01-30       Impact factor: 7.124

Review 7.  Neonatal screening--should we or shouldn't we?

Authors:  P H Weller; J V West
Journal:  J R Soc Med       Date:  1991       Impact factor: 5.344

8.  Using dried blood spot sampling to improve data quality and reduce animal use in mouse pharmacokinetic studies.

Authors:  Enaksha R Wickremsinhe; Everett J Perkins
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-03       Impact factor: 1.232

9.  Application of DNA analysis in a population-screening program for neonatal diagnosis of cystic fibrosis (CF): comparison of screening protocols.

Authors:  R G Gregg; B S Wilfond; P M Farrell; A Laxova; D Hassemer; E H Mischler
Journal:  Am J Hum Genet       Date:  1993-03       Impact factor: 11.025

10.  Serum immunoreactive trypsin and pancreatic lipase in cystic fibrosis.

Authors:  R Bollbach; M Becker; H W Rotthauwe
Journal:  Eur J Pediatr       Date:  1985-07       Impact factor: 3.183
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.